Practical methods using boronic acid compounds for identification of class C β-lactamase-producing Klebsiella pneumoniae and Escherichia coli

Journal of Clinical Microbiology

Volumn 43, Issue 6, 2005, Pages 2551-2558

  Yagi, Tetsuya ^a,b   Wachino, Jun Ichi ^a   Kurokawa, Hiroshi ^a   Suzuki, Satowa ^a   Yamane, Kunikazu ^a   Doi, Yohei ^a   Shibata, Naohiro ^a   Kato, Haru ^a   Shibayama, Keigo ^a   Arakawa, Yoshichika ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINOBENZENEBORONIC ACID; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; BORONIC ACID DERIVATIVE; CEFOTAXIME; CEFTAZIDIME; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CONTROLLED STUDY; DISK POTENTIATION TEST; DOUBLE DISK SYNERGY TEST; ESCHERICHIA COLI; GENE SEQUENCE; GROWTH INHIBITION; HAFNIA ALVEI; ISOELECTRIC FOCUSING; KLEBSIELLA PNEUMONIAE; METHODOLOGY; MOLECULAR CLONING; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BORONIC ACIDS; CEFOTAXIME; CEFTAZIDIME; ESCHERICHIA COLI; HUMANS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS;

ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE;

EID: 20444481360     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.6.2551-2558.2005     Document Type: Article

References (45)

1. Arakawa, Y., N. Shibata, K. Shibayama, H. Kurokawa, T. Yagi, H. Fujiwara, and M. Goto. 2000. Convenient test for screening metallo-β-lactamase- producing gram-negative bacteria by using thiol compounds. J. Clin. Microbiol. 38:40-43.
2. Barnaud, G., G. Ariel, C. Verdet, O. Gaillot, P. H. Lagrange, and A. Philippen. 1998. Salmonella enteritidis: AmpC plasmid-mediated inducible β-lactamase (DHA-1) with an ampR gene from Morganella morganii. Antimicrob. Agents Chemother. 42:2352-2358.
3. Bauernfeind, A., Y. Chong, and S. Schweighart. 1989. Extended broad-spectrum β-lactamase in Klebsiella pneumoniae including resistance to cephamycins. Infection 17:316-321.
4. Beesley, T., N. Gascoyne, V. Knott-Hunziker, S. Petursson, S. G. Waley, B. Jaurin, and T. Grundstrom. 1982. The inhibition of class C β-lactamases by boronic acids. Biochem. J. 209:229-233.
5. Black, J. A., K. S. Thomson, and J. D. D. Pitout. 2004. Use of β-lactamase inhibitors in disk tests to detect plasmid-mediated AmpC β-lactamases. J. Clin. Microbiol. 42:2203-2206.
6. Bradford, P. A., C. Urban, N. Mariano, S. A. Projan, J. J. Rahal, and K. Bush. 1997. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the loss of an outer membrane protein. Antimicrob. Agents Chemother. 41:563-569.
7. Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211-1233.
8. Buzzoni, V., J. Blazquez, S. Ferrari, S. Calo, A. Venturelli, and M. P. Costi. 2004. Aza-boronic acids as non-β-lactam inhibitors of AmpC-β-lactamase. Bioorg. Med. Chem. Lett. 14:3979-3983.
9. Coudron, P. E., E. S. Moland, and K. S. Thomson. 2000. Occurrence and detection of AmpC β-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center. J. Clin. Microbiol. 38:1791-1796.
10. Doi, Y., N. Shibata, K. Shibayama, K. Kamachi, H. Kurokawa, K. Yokoyama, T. Yagi, and Y. Arakawa. 2002. Characterization of a novel plasmid-mediated cephalosporinase (CMY-9) and its genetic environment in an Escherichia coli clinical isolate. Antimicrob. Agents Chemother. 46:2427-2434.
11. Doi, Y., J. Wachino, M. Ishiguro, H. Kurokawa, K. Yamane, N. Shibata, K. Shibayama, K. Yokoyama, H. Kato, T. Yagi, and Y. Arakawa. 2004. Inhibitor-sensitive AmpC β-lactamase variant produced by an Escherichia coli clinical isolate resistant to oxyiminocephalosporins and cephamycins. Antimicrob. Agents Chemother. 48:2652-2658.
12. Dubois, V., C. Arpin, M. Melon, B. Melon, C. Andre, C. Frigo, and C. Quentin. 2001. Nosocomial outbreak due to a multiresistant strain of Pseudomonas aeroginosa P12: efficacy of cefepime-amikacin therapy and analysis of β-lactam resistance. J. Clin. Microbiol. 39:2072-2078.
13. Fey, P. D., T. J. Safranek, M. E. Rupp, E. F. Dunne, E. Ribot, P. C. Iwen, P. A. Bradford, F. J. Angulo, and S. H. Hinrichs. 2000. Ceftriaxone-resistant Salmonella infection acquired by a child from cattle. N. Engl. J. Med. 27:1242-1249.
14. Hansen, N. D. 2003. AmpC β-lactamases: what do we need to know for the future? J. Antimicrob. Chemother. 52:2-4.
15. Horii, T., Y. Arakawa, M. Ohta, S. Ichiyama, R. Wacharotayankun, and N. Kato. 1993. Plasmid-mediated AmpC-type β-lactamase isolated from Klebsiella pneumoniae confers resistance to broad-spectrum β-lactams, including moxalactam. Antimicrob. Agents Chemother. 37:984-990.
16. Hujer, A. M., M. G. Page, M. S. Helfand, B. Yeiser, and R. A. Bonomo. 2002. Development of a sensitive and specific enzyme-linked immunosorbent assay for detecting and quantifying CMY-2 and SHV β-lactamases. J. Clin. Microbiol. 40:1947-1957.
17. Kurokawa, H., T. Yagi, N. Shibata, K. Shibayama, K. Kamachi, and Y. Arakawa. 2000. A new SHV-derived extended-spectrum β-lactamase (SHV-24) that hydrolyzes ceftazidime through a single-amino-acid substitution (D179G) in the omega-loop. Antimicrob. Agents Chemother. 44:1725-1727.
18. Kurokawa, H., N. Shibata, Y. Doi, K. Shibayama, K. Kamachi, T. Yagi, and Y. Arakawa. 2003. A new TEM-derived extended-spectrum β-lactamase (TEM-91) with an R164C substitution at the omega-loop confers ceftazidime resistance. Antimicrob. Agents Chemother. 47:2981-2983.
19. Liebana, E., M. Gibbs, C. Clouting, L. Barker, F. A. Crifton-Hardley, E. Pleydell, B. Abdalhamid, N. D. Hanson, L. Martin, C. Poppe, and R. H. Davies. 2004. Characterization of β-lactamases responsible for resistance to extended-spectrum cephalosporins in Escherichia coli and Salmonella enterica strains from food-producing animals in the United Kingdom. Microb. Drug Resist. 10:1-9.
20. Livermore, D., and D. F. J. Brown. 2001. Detection of β-lactamase-mediated resistance. J. Antimicrob. Chemother. 48(Suppl. 1):59-64.
21. Livermore, D. M. 1995. β-Lactamases in laboratory and clinical resistance. Clin. Microbiol. Rev. 8:557-584.
22. Manchanda, V., and N. P. Singh. 2003. Occurrence and detection of AmpC β-lactamases among gram-negative clinical isolates using a modified three-dimensional test at Guru Tegh Bahadur Hospital, Deli, India. J. Antimicrob. Chemother. 51:415-418.
23. Morandi, F., E. Caselli, S. Morandi, P. J. Focia, J. Blazquez, B. K. Shoichet, and F. Prati. 2003. Nanomolar inhibitors of AmpC β-lactamase. J. Am. Chem. Soc. 125:685-695.
24. Nadjar, D., M. Rouveau, C. Verdet, J. Donay, P. H. Herrmann, A. Lagrange, A. Philippon, and G. Ariel. 2000. Outbreak of Klebsiella pneumoniae producing transferable AmpC-type β-lactamase (ACC-1) originating from Hafnia alvei. FEMS Microbiol. Lett. 187:35-40.
25. Nagano, N., N. Shibata, Y. Saito, Y. Nagano, and Y. Arakawa. 2003. Nosocomial outbreak of infection by Proteus mirabilis that produces extended-spectrum CTX-M-2 type β-lactamase. J. Clin. Microbiol. 41:5530-5536.
26. Nasim, K., S. Elsayed, J. D. D. Pitout, J. Conly, D. L. Church, and D. B. Gregson. 2004. New method for laboratory detection of AmpC β-lactamases in Escherichia coli and Klebsiella pneumoniae. J. Clin. Microbiol. 42:4799-4802.
27. National Committee for Clinical Laboratory Standards. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 6th ed. Approved standard M7-A6. National Committee for Clinical Laboratory Standards, Wayne, Pa.
28. National Committee for Clinical Laboratory Standards. 2003. Performance standards for antimicrobial disk susceptibility tests, 8th ed. Approved standard M2-A8. National Committee for Clinical Laboratory Standards, Wayne, Pa.
29. National Committee for Clinical Laboratory Standards. 2004. Performance standards for antimicrobial and susceptibility testing: 14th informational supplement (M100-S14). National Committee for Clinical Laboratory Standards, Wayne, Pa.
30. Papanicolaou, G. A., A. A. Medeiros, and G. A. Jacoby. 1990. Novel plasmid-mediated β-lactamase (MIR-1) conferring resistance to oxyimino- and α-methoxy β-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 34:2200-2209.
31. Perez-Perez, F. J., and N. D. Hanson. 2002. Detection of plasmid-mediated AmpC-type β-lactamase genes in clinical isolates by using multiplex PCR. J. Clin. Microbiol. 40:2153-2162.
32. Philippon, A., G. Ariel, G. A. Jacoby. 2002. Plasmid-determined AmpC-type β-lactamases. Antimicrob. Agents Chemother. 46:1-11.
33. Pitout, J. D., M. D. Reisbig, E. C. Venter, D. L. Church, and N. D. Hanson. 2003. Modification of the double-disk test for detection of Enterobacteriaceae producing extended-spectrum and AmpC β-lactamases. J. Clin. Microbiol. 41:3933-3935.
34. Powers, R. A., J. Blazquez, G. Scott Weston, M. Morosini, F. Baquero, and B. K. Shoichet. 1999. The complexed structure and antimicrobial activity of a non-β-lactam inhibitor of AmpC β-lactamase. Protein Sci. 8:2330-2337.
35. Qin, X., S. J. Weissman, M. F. Chesnut, B. Zhang, and L. Shen. 2004. Kirby-Bauer disk approximation to detect inducible third-generation cephalosporin resistance in Enterobacteriaceae. Ann. Clin. Microbiol. Antimicrob. 3:13.
36. Queenan, A. M., S. Jenkins, and K. Bush. 2001. Cloning and biochemical characterization of FOX-5, an AmpC-type plasniid-encoded β-lactamase from a New York City Klebsiella pneumoniae clinical isolate. Antimicrob. Agents Chemother. 45:3189-3194.
37. Scott Weston, G., J. Blazquez, F. Baquero, and B. K. Shoichet. 1998. Structure-based enhancement of boronic acid-based inhibitors of AmpC β-lactamase. J. Med. Chem. 41:4577-4586.
38. Shibata, N., Y. Doi, K. Yamane, T. Yagi, H. Kurokawa, K. Shibayama, H. Kato, K. Kai, and Y. Arakawa. 2003. PCR typing of genetic determinants for metallo-β-lactamases and integrases carried by gram-negative bacteria isolated in Japan, with focus on the class 3 integron. J. Clin. Microbiol. 41:5407-5413.
39. Thomson, K. S., and C. C. Sanders. 1992. Detection of extended-spectrum β-lactamases in members of the family Enterobacteriaceae: comparison of the double-disk test and three-dimensional tests. Antimicrob. Agents Chemother. 36:1877-1882.
40. Tzouvelekis, L. S., E. Tzelepi, A. F. Mentis, and A. Tsakris. 1993. Identification of a novel plasmid-mediated β-lactamase with chromosomal cephalosporinase characteristics in Klebsiella pneumoniae. J. Antimicrob. Chemother. 31:645-654.
41. Usher, K. C., L. C. Blaszczak, G. Scott Weston, B. K. Shoichet, and S. J. Remington. 1998. Three-dimensional structure of AmpC β-lactamase from Escherichia coli bound to a transition-state analogue: possible implications for the oxyanion hypothesis and inhibitor design. Biochemistry 37:16082-16092.
42. Wachino, J., Y. Doi, K. Yamane, N. Shibata, T. Yagi, T. Kubota, H. Ito, and Y. Arakawa. 2004. Nosocomial spread of ceftazidime-resistant Klebsiella pneumoniae strains producing a novel class A β-lactamase, GES-3, in a neonatal intensive care unit in Japan. Antimicrob. Agents Chemother. 48:1960-1967.
43. Wachino, J., Y. Doi, K. Yamane, N. Shibata, T. Yagi, T. Kubota, and Y. Arakawa. 2004. Molecular characterization of a cephamycin-hydrolyzing and inhibitor-resistant class A β-lactamase, GES-4, possessing a single G170S substitution in the omega-loop. Antimicrob. Agents Chemother. 48:2905-2910.
44. Yagi, T., H. Kurokawa, N. Shibata, K. Shibayama, and Y. Arakawa. 2000. A preliminary survey of extended-spectrum β-lactamases (ESBLs) in clinical isolates of Klebsiella pneumoniae and Eschenchia coli in Japan. FEMS Microbiol. Lett. 184:112-119.
45. Yong, D., R. Park, J. H. Yum, K. Lee, E. C. Choi, and Y. Chong. 2002. Further modification of the Hodge test to screen AmpC β-lactamase (CMY-1)-producing strains of Escherichia coli and Klebsiella pneumoniae. J. Microbiol. Methods 51:407-410.